Literature DB >> 3624667

Cardiac and skeletal muscle abnormalities in cardiomyopathy: comparison of patients with ventricular tachycardia or congestive heart failure.

A Dunnigan, N A Staley, S A Smith, M E Pierpont, D Judd, D G Benditt, D W Benson.   

Abstract

Results of cardiac muscle and skeletal muscle biopsies were compared in 22 patients with cardiomyopathy; 11 patients presented with symptoms secondary to ventricular tachycardia (Group 1) and 11 had symptoms of severe congestive heart failure (Group 2). No patient had structural or ischemic cardiac disease. In Group 1 patients, hemodynamic abnormalities were subtle, but invasive study demonstrated dilated cardiomyopathy in two patients and restrictive cardiomyopathy in nine. In Group 2, eight patients had dilated cardiomyopathy and three had restrictive cardiomyopathy. Cardiac biopsy results were abnormal in all 22 patients and the abnormalities were similar for the two groups. Cardiac histologic study revealed a spectrum of abnormalities including fibrosis, dilated sarcoplasmic reticulum, increased numbers of intercalated discs and mitochondrial abnormalities. Histologic abnormalities of skeletal muscle were similar in each group, consisting of endomysial fibrosis and increased lipid deposits. Slightly more than half of the Group 1 and Group 2 patients also had a low concentration of skeletal muscle long chain acylcarnitine. These data demonstrate that abnormalities of both cardiac and skeletal muscle are common in patients with cardiomyopathy; abnormalities are similar whether initial symptoms are due to ventricular tachycardia or congestive heart failure. It is suggested that these patients with cardiomyopathy may have a generalized myopathy.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3624667     DOI: 10.1016/s0735-1097(87)80204-8

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  10 in total

Review 1.  Exercise training as therapy for chronic heart failure.

Authors:  N G Uren; D P Lipkin
Journal:  Br Heart J       Date:  1992-06

2.  Ultrastructural abnormalities of mitochondria and deficiency of myocardial cytochrome c oxidase in a patient with ventricular tachycardia.

Authors:  B Schwartzkopff; S Zierz; H Frenzel; M Block; E Neuen-Jacob; K Reiners; B E Strauer
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

Review 3.  Ventricular tachycardia in children: an overview.

Authors:  A V Mehta
Journal:  Indian J Pediatr       Date:  1991 Sep-Oct       Impact factor: 1.967

Review 4.  Extracardiac medical and neuromuscular implications in restrictive cardiomyopathy.

Authors:  Claudia Stöllberger; Josef Finsterer
Journal:  Clin Cardiol       Date:  2007-08       Impact factor: 2.882

Review 5.  Peripheral circulatory adaptations to pump failure of the heart.

Authors:  H Drexler
Journal:  Br Heart J       Date:  1994-08

6.  Pulmonary function and respiratory muscle strength in chronic heart failure: comparison between ischaemic and idiopathic dilated cardiomyopathy.

Authors:  M Daganou; I Dimopoulou; P A Alivizatos; G E Tzelepis
Journal:  Heart       Date:  1999-06       Impact factor: 5.994

7.  Grading the severity of congestive heart failure in infants.

Authors:  R D Ross; R O Bollinger; W W Pinsky
Journal:  Pediatr Cardiol       Date:  1992-04       Impact factor: 1.655

Review 8.  Cardiac rehabilitation in heart failure with severely reduced ejection fraction: effects on mortality.

Authors:  Negin Sadat Hosseini Mohammadi; Mohammad Hasan Shaki Katouli; Farzad Masoudkabir; Alipasha Meysamie; Kiarash Tavakoli; Ali Vasheghani-Farahani
Journal:  Heart Fail Rev       Date:  2022-05-21       Impact factor: 4.214

9.  Cardiac dysrhythmias in children with idiopathic dilated or hypertrophic cardiomyopathy.

Authors:  G Müller; H E Ulmer; K J Hagel; D Wolf
Journal:  Pediatr Cardiol       Date:  1995 Mar-Apr       Impact factor: 1.655

10.  Angiotensin-converting-enzyme inhibitor prevents skeletal muscle fibrosis in myocardial infarction mice.

Authors:  Naoya Kakutani; Shingo Takada; Hideo Nambu; Junichi Matsumoto; Takaaki Furihata; Takashi Yokota; Arata Fukushima; Shintaro Kinugawa
Journal:  Skelet Muscle       Date:  2020-04-25       Impact factor: 4.912

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.